Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RZLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 96.29M
December 31, 2025 95.55M
September 30, 2025 91.04M
June 30, 2025 87.00M
March 31, 2025 60.54M
December 31, 2024 60.54M
September 30, 2024 55.39M
June 30, 2024 53.25M
March 31, 2024 40.13M
December 31, 2023 39.62M
September 30, 2023 36.83M
June 30, 2023 36.83M
March 31, 2023 36.83M
December 31, 2022 36.83M
September 30, 2022 36.83M
June 30, 2022 33.58M
March 31, 2022 15.56M
December 31, 2021 15.56M
September 30, 2021 8.64M
June 30, 2021 8.352M
March 31, 2021 8.352M
December 31, 2020 8.352M
September 30, 2020 5.867M
June 30, 2020 5.867M
March 31, 2020 5.866M
Date Value
December 31, 2019 5.866M
September 30, 2019 5.866M
June 30, 2019 4.208M
March 31, 2019 1.237M
December 31, 2018 1.237M
September 30, 2018 1.243M
June 30, 2018 1.243M
March 31, 2018 1.082M
December 31, 2017 1.082M
September 30, 2017 1.075M
June 30, 2017 0.9846M
March 31, 2017 0.909M
December 31, 2016 0.819M
September 30, 2016 0.7512M
June 30, 2016 0.7022M
March 31, 2016 0.4868M
December 31, 2015 0.4868M
September 30, 2015 0.4868M
June 30, 2015 0.4868M
March 31, 2015 0.4707M
December 31, 2014 0.4401M
September 30, 2014 0.3644M
June 30, 2014 0.3618M
March 31, 2014 0.0487M
December 31, 2013 0.1333M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. 201.92M
AbbVie, Inc. 1.767B
Marker Therapeutics, Inc. 16.67M
Avalo Therapeutics, Inc. 52.90M
Krystal Biotech, Inc. 29.60M